ECM Weekly (18 April 2019) - Duiba Group, MabPharm, Huami, Cofco Meat, Innovent, Times China
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
861 Views
Innovent Biologics (信达生物) Placement - Selling upon Lock-Up Expiry
Undisclosed shareholders of Innovent Biologics Inc (1801 HK) is looking to sell part of its stake (36.2m shares, about US$125m) in the company. The...
878 Views
Keytruda Approved for Lung Cancer Treatment in China - A Review of PD-1 Battle Field
Anti-PD-1 monoclonal antibody (mAb) is a hotly contested immunotherapy area in China, with seven companies working on clinical trials covering...
620 Views
CStone Pharma (基石药业) Post-IPO: Strong Debut but Lacks near Term Catalysts
CStone Pharma's IPO was priced at HKD 12.00/share and started trading today. In this insight, we summarize the allocation, the use of proceeds and...
548 Views
CStone Pharma (基石药业) IPO: Thoughts on Valuation (Part 2)
CStone Pharma, a Wuxi Apptec related biotech company, plans to raise USD 300m to list on the Hong Kong Stock Exchange. In our previous insight...
758 Views